| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/23/2013 | WO2013072542A1 Adjuvant effect of the vaccinia virus a27 protein (14k) and the use thereof in vaccines |
| 05/23/2013 | WO2013071440A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | WO2013048185A3 Method for forming a reversible protein nanocluster using light in a cell |
| 05/23/2013 | WO2012175924A3 Incorporation of substituted lysines into polypeptides |
| 05/23/2013 | WO2012142113A8 Isopeptide bond formation in bacillus species and uses thereof |
| 05/23/2013 | US20130130967 Method for Uses of Protein Precursors as Prodrugs |
| 05/23/2013 | US20130129727 Methods and systems for increasing protein stability |
| 05/23/2013 | CA2855653A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | CA2854809A1 Compositions and methods for treating autoimmune and inflammatory disorders |
| 05/22/2013 | EP2594584A1 Engineered constant domain molecule of an antibody |
| 05/22/2013 | CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof |
| 05/22/2013 | CN103113473A TAT-LBD-NEP1-40 fusion protein, construction method and application thereof |
| 05/22/2013 | CN103113472A Fusion peptide with myocardial preservation function as well as preparation method and application thereof |
| 05/22/2013 | CN103113470A Genetically engineered lymphocyte targeting Human EGFR (Epidermal Growth Factor Receptor), preparation method and application of genetically engineered lymphocyte |
| 05/22/2013 | CN102372782B Insect antibacterial peptide diapause specific peptide (DSP) fusion protein and application thereof to plant disease resistance |
| 05/22/2013 | CN102372781B Insect antibacterial peptide thanatin (s) fusion protein and application thereof to plant disease resistance |
| 05/22/2013 | CN102199214B Protein preparation method |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/21/2013 | CA2279329C Protein fragment complementation assays to detect biomolecular interactions |
| 05/16/2013 | WO2013068847A2 Compositions and methods for treatment of cytomegalovirus |
| 05/16/2013 | US20130122003 Methods of inhibiting tumor growth by antagonizing il-6 receptor |
| 05/16/2013 | US20130121995 Compositions and Methods for Increasing Bone Mineralization |
| 05/16/2013 | DE69132920C5 Methode zur Herstellung von filamentösen, antikörper-präsentierenden Bakteriophagenpartikeln durch Verwendung von Phagemiden und die daduch hergestellten Bakteriophagenpartikel Method for the production of filamentous bacteriophage particles by antibody-presenting use of phagemids and the bacteriophage produced Daduchus |
| 05/15/2013 | EP2591006A1 Processable single chain molecules and polypeptides made using same |
| 05/15/2013 | EP2590994A1 Vaccine against streptococcal infections based on recombinant proteins |
| 05/15/2013 | CN103102418A Fusion protein of granulocyte colony-stimulating factor (G-CSF) as well as mutant of granulocyte colony-stimulating factor (mG-CSF) and human serum albumin 3rd domain (3DHSA) and application |
| 05/15/2013 | CN103102417A Purification method of recombinant human interferon alpha 2b-CTP fusion protein |
| 05/15/2013 | CN103102416A Recombinant fusion protein of IL3 and Lidamycin, preparation method and application thereof |
| 05/15/2013 | CN101679500B G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 05/14/2013 | CA2687377C Immunoglobulin fusion proteins |
| 05/14/2013 | CA2477878C Peptides selectively lethal to malignant and transformed mammalian cells |
| 05/14/2013 | CA2242342C Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 05/10/2013 | WO2013067173A1 Systematic control of protein interaction using a modular er/k linker |
| 05/10/2013 | WO2013067160A2 Anti-bacterial polypeptides and pathogen specific synthetic antibodies |
| 05/10/2013 | WO2013066365A1 Immunologic constructs and methods |
| 05/10/2013 | WO2013066047A1 Fusion protein comprising c-terminal domain of ret protein and use thereof as a diagnosing marker |
| 05/10/2013 | WO2013065343A1 Peptide-hinge-free flexible antibody-like molecule |
| 05/10/2013 | WO2013064700A2 Chimeric polypeptides and methods of use |
| 05/10/2013 | WO2013063877A1 Glp-1 derivate dlg3312 and solid-phase chemical synthesis method thereof |
| 05/10/2013 | WO2013040309A3 Wnt compositions and therapeutic uses of such compositions |
| 05/10/2013 | CA2853816A1 Methods of preparing lyophilized spherical-shaped pellets of biological materials |
| 05/09/2013 | US20130116165 Light-activated fusion proteins and uses therefor |
| 05/09/2013 | US20130115634 Peptides and methods for the detection of lyme disease antibodies |
| 05/09/2013 | US20130115191 T cell receptor fusions and conjugates and methods of use thereof |
| 05/08/2013 | EP2589605A1 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 05/08/2013 | EP2588490A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 05/08/2013 | EP2588129A2 Small-molecule-targeted protein degradation |
| 05/08/2013 | EP2502939A9 Nonnatural collagen-like protein and use thereof |
| 05/08/2013 | CN103097524A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
| 05/08/2013 | CN103097523A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl tRNA synthetases |
| 05/08/2013 | CN103097408A Method for producing cAMP using chimeric olfactory receptor |
| 05/08/2013 | CN103097403A Chlorotoxin variants, conjugates, and methods for their use |
| 05/08/2013 | CN103088060A Vaccine composition |
| 05/08/2013 | CN103087200A Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein |
| 05/08/2013 | CN103087199A Gastric cancer targeted recombinant toxin and preparation method thereof |
| 05/08/2013 | CN103087198A MRSA (Methicillin Resistant Staphylococcus Aureus) vaccine recombinant protein antigen I1C and preparation method and application thereof |
| 05/08/2013 | CN103087197A Phycoerythrin-labeled anti-STI (soybean trypsin inhibitor) antibody, preparation method and use thereof |
| 05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
| 05/08/2013 | CN103087172A Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/08/2013 | CN103087156A Foot and mouth disease virus (FMDV) antigen polypeptide and vaccine |
| 05/08/2013 | CN103087154A Polypeptide for preparing monoclonal antibody for detecting acetylcholin esterase and application of polypeptide |
| 05/08/2013 | CN103083651A Cell-penetrating peptide-mediated botulinum toxin composition for external preparation as well as preparation method and application of botulinum toxin composition |
| 05/08/2013 | CN102241776B RANKL-TNF (Receptor Activator of Nuclear Factor Kappa-B Ligand-Tumour Necrosis Factor) sample region fusion protein and preparation method and application thereof |
| 05/08/2013 | CN102180972B Preparation of standard substance for quantitative detection of tubercle bacillus culture filtrate protein 10 (CFP-10) |
| 05/08/2013 | CN102120772B Chimeric antibody and immunocyte |
| 05/08/2013 | CN101712964B Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof |
| 05/08/2013 | CN101588818B Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 05/07/2013 | US8436148 Antibodies against interleukin-18 binding protein, their preparation and use |
| 05/07/2013 | US8436143 T1R taste receptors and genes encoding same |
| 05/07/2013 | US8435762 Chimeric ligand-gated ion channels and methods of use thereof |
| 05/07/2013 | US8435537 System for the expression of peptides on the bacterial surface |
| 05/07/2013 | CA2572555C Fusion protein of porcine reproductive and respiratory syndrome virus as prrs vaccine |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/02/2013 | WO2013063309A1 Gigaxonin fusion protein and methods for treating giant axonal neuropathy |
| 05/02/2013 | WO2013063248A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
| 05/02/2013 | WO2013062365A2 Mutant ctla4 gene transfected t cell and composition including same for anticancer immunotherapy |
| 05/02/2013 | WO2013061818A1 Novel peptide complex and hybrid complex thereof, and use of said hybrid complex |
| 05/02/2013 | WO2013061273A1 A modified effector cell (or chimeric receptor) for treating disialoganglioside gd2 -expressing neoplasia |
| 05/02/2013 | WO2013060052A1 Hypoallergenic recombinant immunotoxin, and preparation method and application thereof |
| 05/02/2013 | WO2013059885A2 Polypeptide constructs and uses thereof |
| 05/02/2013 | WO2013025846A3 Transferrin-tumstatin fusion protein and methods for producing and using the same |
| 05/02/2013 | WO2013022320A3 Amphipathic peptide-lipase conjugate having advanced lipase activity and use thereof |
| 05/02/2013 | WO2012162561A3 Multivalent and monovalent multispecific complexes and their uses |
| 05/02/2013 | CA2852955A1 Methods and compositions for modification of the hprt locus |
| 05/02/2013 | CA2851892A1 Polypeptide constructs and uses thereof |
| 05/01/2013 | EP2585107A1 Homodimeric protein constructs |
| 05/01/2013 | CN103080125A Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 05/01/2013 | CN103074353A Synthetic Bt bivalent fusion protein with high virulence against lepidoptera, and coding gene thereof |
| 05/01/2013 | CN103073646A Polypeptide carrying melittin, nano-particles carrying melittin, and applications thereof |
| 05/01/2013 | CN103073643A Fertilin Beta extracellular domain high-titer antibody prepared by GST expression system and application thereof |
| 05/01/2013 | CN103073639A Stabilized polypeptide compositions |
| 05/01/2013 | CN102370979B Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule |
| 05/01/2013 | CN102286106B Sandwich outer membrane protein display vector and escherichia coli vaccine prepared by applying same |
| 05/01/2013 | CN102031266B Insect-resistant fusion gene, fused protein and application of fused protein |
| 05/01/2013 | CN101591640B Method for inducing somatic cell to reprogram by penetrating stem cell transcription factor |
| 05/01/2013 | CN101384617B Multimeric complexes of antigens and an adjuvant |
| 04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
| 04/30/2013 | CA2503125C Novel composition and methods for the treatment of immune related diseases |
| 04/30/2013 | CA2403964C Compositions and methods for dendritic cell-based immunotherapy |